ORGANOGENESIS HOLDINGS INC. Common Stock, Capital Shares Reserved for Future Issuance
ORGANOGENESIS HOLDINGS INC. (ORGO) had Common Stock, Capital Shares Reserved for Future Issuance of 18.14 million shares as of 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Notes › Equity
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2024-02-29
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 18.14M shares.
- 2023-09-30: Common Stock, Capital Shares Reserved for Future Issuance 18.27M shares.
- 2023-06-30: Common Stock, Capital Shares Reserved for Future Issuance 18.30M shares.
- 2023-03-31: Common Stock, Capital Shares Reserved for Future Issuance 18.40M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2023-12-31 | 18.14M shares 10-K · filed 2024-02-29 | |
| 2023-09-30 | 18.27M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 18.30M shares 10-Q · filed 2023-08-09 | |
| 2023-03-31 | 18.40M shares 10-Q · filed 2023-05-10 | |
| 2022-12-31 | 18.71M shares 10-K · filed 2024-02-29 | |
| 2022-09-30 | 18.76M shares 10-Q · filed 2022-11-09 | |
| 2022-06-30 | 18.79M shares 10-Q · filed 2022-08-09 | |
| 2022-03-31 | 12.79M shares 10-Q · filed 2022-05-10 | |
| 2021-12-31 | 13.01M shares 10-K · filed 2023-03-01 | |
| 2021-09-30 | 13.13M shares 10-Q · filed 2021-11-09 | |
| 2021-06-30 | 13.50M shares 10-Q · filed 2021-08-09 | |
| 2021-03-31 | 13.68M shares 10-Q · filed 2021-05-11 | |
| 2020-12-31 | 14.06M shares 10-K · filed 2022-03-01 | |
| 2020-09-30 | 14.43M shares 10-Q · filed 2020-11-09 | |
| 2020-06-30 | 14.63M shares 10-Q · filed 2020-08-10 | |
| 2020-03-31 | 14.93M shares 10-Q · filed 2020-05-11 | |
| 2019-12-31 | 15.51M shares 10-K · filed 2021-03-16 | |
| 2019-09-30 | 15.60M shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 33.34M shares 10-Q · filed 2019-08-09 | |
| 2019-03-31 | 33.37M shares 10-Q · filed 2019-05-10 | |
| 2018-12-31 | 33.43M shares 10-K · filed 2020-03-09 | 33.43M shares 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |